Why Should I Vote On BetterDistricts?

Polling is a powerful tool to help our elected officials determine how they should vote.

Standard polling methods don't give you the control that you deserve. With BetterDistricts you can show your representative exactly how strongly a bill is supported in your community.

Send a clear signal on how you want your government to work.

H.R. 1660 - Global Health Innovation Act of 2017
Sponsor: Albio Sires (D)
Introduced: 2018-01-19
Bill Status: Placed on Senate Legislative Calendar under General Orders. Calendar No. 364.
 

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Global Health Innovation Act of 2017

(Sec. 2) This bill directs the Administrator of the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

Such reports shall include descriptions of: (1) goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

Full Text

Calendar No. 364

115th CONGRESS
2d Session
H. R. 1660


    To direct the Administrator of the United States Agency for International Development to submit to Congress a report on the development and use of global health innovations in the programs, projects, and activities of the Agency.


IN THE SENATE OF THE UNITED STATES

January 19, 2018

    Received; read twice and referred to the Committee on Foreign Relations

March 22, 2018

    Reported by Mr. Corker, without amendment


AN ACT

    To direct the Administrator of the United States Agency for International Development to submit to Congress a report on the development and use of global health innovations in the programs, projects, and activities of the Agency.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Global Health Innovation Act of 2017”.

SEC. 2. Annual report.

(a) In general.—Not later than 180 days after the date of the enactment of this Act, and annually thereafter for a period of 4 years, the Administrator of the United States Agency for International Development shall submit to Congress a report on the development and use of global health innovations in the programs, projects, and activities of the Agency.

(b) Matters To Be Included.—The report required by subsection (a) shall include the following:

(1) A description of—

(A) the extent to which global health innovations described in subsection (a) include drugs, diagnostics, devices, vaccines, electronic and mobile health technologies, and related behavior change and service delivery innovations;

(B) how innovation has advanced the Agency’s commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases, as well as furthered by the Global Health Strategic Framework;

(C) how goals are set for health product development in relation to the Agency’s health-related goals and how progress and impact are measured towards those goals;

(D) how the Agency’s investments in innovation relate to its stated goals; and

(E) progress made towards health product development goals.

(2) How the Agency, both independently and with partners, donors, and public-private partnerships, is—

(A) leveraging United States investments to achieve greater impact in health innovation;

(B) engaging in activities to develop, advance, and introduce affordable, available, and appropriate global health products; and

(C) scaling up appropriate health innovations in the development pipeline.

(3) A description of collaboration and coordination with other Federal departments and agencies, including the Centers for Disease Control and Prevention, in support of global health product development, including a description of how the Agency is working to ensure critical gaps in product development for global health are being filled.

(4) A description of how the Agency is coordinating and aligning global health innovation activities between the Global Development Lab, the Center for Accelerating Innovation and Impact, and the Bureau for Global Health.


Calendar No. 364

115th CONGRESS
     2d Session
H. R. 1660

AN ACT
    To direct the Administrator of the United States Agency for International Development to submit to Congress a report on the development and use of global health innovations in the programs, projects, and activities of the Agency.

March 22, 2018
    Reported without amendment

Relevant News Stories And Blog Posts

Title Worth Reading

Vote on H.R. 1660

 

Activity in last 30 days